Gilead Sciences (GILD) EBIT Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
660.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-179.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-138.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-6,345.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
1,648.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
360.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
2,760.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-103.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
360.00 |
| Dec 31, 2025 |
-736.00 |
| Sep 30, 2025 |
3,105.00 |
| Jun 30, 2025 |
-309.00 |
| Mar 31, 2025 |
9,820.00 |
| Dec 31, 2024 |
974.00 |
| Sep 30, 2024 |
-2,543.00 |
| Jun 30, 2024 |
1,279.00 |
| Mar 31, 2024 |
-9,148.00 |
| Dec 31, 2023 |
-802.00 |
| Sep 30, 2023 |
-309.00 |
| Jun 30, 2023 |
-718.00 |
| Mar 31, 2023 |
2,385.00 |
| Dec 31, 2022 |
1,770.00 |
| Sep 30, 2022 |
-1,149.00 |
| Jun 30, 2022 |
-371.00 |
| Mar 31, 2022 |
-4,201.00 |
| Dec 31, 2021 |
-2,275.00 |
| Sep 30, 2021 |
2,135.00 |
| Jun 30, 2021 |
9,413.00 |
| Mar 31, 2021 |
170.00 |
| Dec 31, 2020 |
1,713.00 |
| Sep 30, 2020 |
5,671.00 |
| Jun 30, 2020 |
-10,075.00 |
| Mar 31, 2020 |
94.00 |
| Dec 31, 2019 |
-115.00 |
| Sep 30, 2019 |
-7,316.00 |
| Jun 30, 2019 |
238.00 |
| Mar 31, 2019 |
4.00 |
| Dec 31, 2018 |
839.00 |
| Sep 30, 2018 |
-1,167.00 |
| Jun 30, 2018 |
-1,920.00 |
| Mar 31, 2018 |
-1,559.00 |
| Dec 31, 2017 |
-4,391.00 |
| Sep 30, 2017 |
-12.00 |
| Jun 30, 2017 |
121.00 |
| Mar 31, 2017 |
-176.00 |
| Dec 31, 2016 |
-1,082.00 |
| Sep 30, 2016 |
-868.00 |
| Jun 30, 2016 |
-976.00 |
| Mar 31, 2016 |
-1,105.00 |
| Dec 31, 2015 |
688.00 |
| Sep 30, 2015 |
973.00 |
| Jun 30, 2015 |
61.00 |
| Mar 31, 2015 |
985.00 |
| Dec 31, 2014 |
2,083.00 |
| Sep 30, 2014 |
1,635.00 |
| Jun 30, 2014 |
2,581.00 |
| Mar 31, 2014 |
2,038.00 |
| Dec 31, 2013 |
-440.00 |
| Sep 30, 2013 |
-177.00 |
| Jun 30, 2013 |
-233.00 |
| Mar 31, 2013 |
543.00 |
| Dec 31, 2012 |
334.00 |
| Sep 30, 2012 |
-429.00 |
| Jun 30, 2012 |
-354.00 |
| Mar 31, 2012 |
-1,177.00 |
| Dec 31, 2011 |
-207.00 |
| Sep 30, 2011 |
-322.00 |
| Jun 30, 2011 |
-393.00 |
| Mar 31, 2011 |
-884.00 |
| Dec 31, 2010 |
-1,093.00 |
| Sep 30, 2010 |
88.00 |
| Jun 30, 2010 |
530.00 |
| Mar 31, 2010 |
285.00 |
